867034-08-0 Usage
Uses
Used in Pharmaceutical Development:
7-chloro-1H-pyrrolo[2,3-c]pyridine-2-carboxylic acid is used as a key intermediate in the synthesis of pharmaceuticals for its potential to create biologically active molecules. Its unique structure allows for the development of new drugs with specific therapeutic properties.
Used in Agrochemical Synthesis:
In the agrochemical industry, 7-chloro-1H-pyrrolo[2,3-c]pyridine-2-carboxylic acid is utilized as a precursor for the development of novel agrochemicals. Its ability to form various derivatives makes it a valuable component in creating effective and targeted pest control agents.
Potential Pharmaceutical Agent:
7-chloro-1H-pyrrolo[2,3-c]pyridine-2-carboxylic acid may also have direct biological activity, suggesting its potential as a pharmaceutical agent. Further research and development could reveal its therapeutic applications in treating specific diseases or conditions.
Further Research and Development:
As a compound with potential applications in various fields, 7-chloro-1H-pyrrolo[2,3-c]pyridine-2-carboxylic acid is a subject of ongoing research and development. Its exploration could lead to new discoveries and innovations in both the pharmaceutical and agrochemical industries.
Check Digit Verification of cas no
The CAS Registry Mumber 867034-08-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,7,0,3 and 4 respectively; the second part has 2 digits, 0 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 867034-08:
(8*8)+(7*6)+(6*7)+(5*0)+(4*3)+(3*4)+(2*0)+(1*8)=180
180 % 10 = 0
So 867034-08-0 is a valid CAS Registry Number.
867034-08-0Relevant academic research and scientific papers
6-AZAINDOLE COMPOUND
-
, (2008/06/13)
A compound represented by the formula (I) wherein R1, R2, R3 and R6 are the same or different and each is a hydrogen atom or a substituent; one of R4 and R5 is a hydrogen atom and the other is a group represented by the formula: -C(=X)-R7 wherein X is N-O-R8 or N-NH-R9 wherein R8 and R9 are the same or different and each is a hydrogen atom or a group bonded via a carbon atom; and R7 is a hydrogen atom or a substituent, and the like and a salt thereof have a superior IκB kinase inhibitory activity, and useful as pharmaceutical agents such as agents for preventing or treating diabetes and the like.
